A €28 million programme brings together universities, charities and industry to advance precision oncology in Ireland and develop tailored cancer diagnostics and treatments.
Childhood cancer cases are increasing across the European Union, with newly released data from the European Cancer Information System (ECIS) showing a clear upward trend in diagnoses.
Each September, Childhood Cancer Awareness Month brings attention to the fight against pediatric cancers. One of the promising projects currently making waves in this field is MONALISA, a Horizon Europe-funded initiative under the EU Cancer Mission.
Dr Rubina Ahmed, Director of Research, Policy and Services at Blood Cancer UK, explains the urgent need for investment, research, and early diagnosis to beat blood cancer within a generation.
A state-of-the-art facility in Darlington is set to fast-track the development of next-generation RNA therapies thanks to nearly £30 million in government funding.
If technology seeks to transform oncology practice, it must solve three big needs: data, training and trust. Annemiek Snoeckx, Co-Chair of the Digital Health Network at the European Cancer Organisation, explains.
Surabhi Srivastava, Commercial Head UK and EU at Qure.ai, discusses how integrating artificial intelligence can reduce chest X-ray reporting times and accelerate early lung cancer diagnosis.
Researchers have shown that AI can detect early laryngeal cancer and related lesions from voice recordings, offering a simple, non-invasive screening option.
Researchers have developed a lung cancer treatment that delivers healthy mitochondria to tumours, boosting T cell activity and improving the effectiveness of cisplatin chemotherapy with reduced toxicity.
The Lancet Commission finds that over three in five liver cancer cases are due to modifiable risks like hepatitis, alcohol, and obesity, highlighting urgent prevention needs.
The NHS Cancer Programme has awarded £14.4 million through SBRI Healthcare to support 16 pioneering projects aimed at improving early cancer detection and diagnosis across the UK.
UC Berkeley scientists unveil a powerful new at-home test using nanotech and AI to detect diseases like COVID-19 and cancer with unprecedented sensitivity.
